US Stock MarketDetailed Quotes

ARQT Arcutis Biotherapeutics

Watchlist
  • 8.490
  • -0.010-0.12%
Close Aug 16 16:00 ET
  • 8.520
  • +0.030+0.35%
Post 20:01 ET
992.40MMarket Cap-4994P/E (TTM)

Arcutis Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
32.14%-45.12M
60.67%-31.6M
4.14%-247.06M
20.86%-56.24M
35.03%-43.98M
-7.27%-66.49M
-41.02%-80.34M
-47.58%-257.72M
-37.43%-71.07M
-65.58%-67.7M
Net income from continuing operations
26.28%-52.33M
55.83%-35.38M
15.83%-262.14M
7.96%-66.28M
58.44%-44.77M
-5.32%-70.99M
-24.53%-80.1M
-50.93%-311.46M
-0.97%-72.02M
-89.03%-107.71M
Operating gains losses
---112K
---543K
--849K
----
----
----
----
----
----
----
Depreciation and amortization
-9.07%351K
-1.38%358K
62.85%1.52M
10.95%385K
37.23%387K
149.03%386K
142.00%363K
105.73%934K
155.15%347K
143.10%282K
Other non cash items
1.28%1.11M
1.85%1.1M
-86.52%4.39M
1.09%1.11M
-96.37%1.11M
129.89%1.09M
129.51%1.08M
10,435.60%32.56M
1,364.00%1.1M
40,046.05%30.51M
Change In working capital
25.48%-4.27M
39.57%-5.44M
-130.97%-23.5M
105.54%411K
-844.53%-9.18M
-60.30%-5.73M
-2,029.08%-9.01M
-381.08%-10.18M
-157.76%-7.41M
-86.86%1.23M
-Change in receivables
-16.65%-5.18M
-163.21%-11.35M
-105.12%-17.35M
-6.02%-6.39M
9.09%-2.21M
---4.44M
---4.31M
---8.46M
---6.03M
---2.43M
-Change in inventory
67.08%-633K
89.10%-113K
25.21%-5.62M
124.29%779K
20.15%-3.44M
---1.92M
---1.04M
---7.51M
---3.21M
---4.31M
-Change in prepaid assets
-335.50%-2.17M
329.32%5.54M
-348.30%-8.62M
24.98%1.47M
-3,680.42%-8.59M
-55.27%921K
---2.42M
147.37%3.47M
196.62%1.17M
-93.50%240K
-Change in payables and accrued expense
3,291.80%3.89M
160.94%660K
217.11%8.75M
491.98%4.72M
-33.32%5.23M
97.80%-122K
-222.32%-1.08M
-74.24%2.76M
-94.33%798K
39.86%7.84M
-Change in other current liabilities
-10.98%-182K
-12.50%-180K
-51.73%-657K
-12.00%-168K
-52.78%-165K
-86.36%-164K
-83.91%-160K
-278.19%-433K
-552.17%-150K
-217.39%-108K
Cash from discontinued investing activities
Operating cash flow
32.14%-45.12M
60.67%-31.6M
4.14%-247.06M
20.86%-56.24M
35.03%-43.98M
-7.27%-66.49M
-41.02%-80.34M
-47.58%-257.72M
-37.43%-71.07M
-65.58%-67.7M
Investing cash flow
Cash flow from continuing investing activities
-169.72%-62.14M
-126.63%-28.7M
306.69%180.23M
-247.36%-62.19M
123.09%45.55M
69.54%89.12M
604.39%107.75M
-14.81%-87.2M
79.59%42.2M
-5,783.15%-197.26M
Net PPE purchase and sale
--0
--0
-28.53%-428K
95.12%-6K
-966.67%-64K
-245.00%-276K
33.87%-82K
66.53%-333K
52.87%-123K
95.62%-6K
Net intangibles purchase and sale
----
----
--0
--0
----
----
----
---22.95M
--0
----
Net investment purchase and sale
-169.51%-62.14M
-126.61%-28.7M
382.65%180.66M
-246.91%-62.18M
126.17%45.61M
69.81%89.39M
599.26%107.83M
14.73%-63.92M
78.13%42.32M
-4,931.10%-174.31M
Cash from discontinued investing activities
Investing cash flow
-169.72%-62.14M
-126.63%-28.7M
306.69%180.23M
-247.36%-62.19M
123.09%45.55M
69.54%89.12M
604.39%107.75M
-14.81%-87.2M
79.59%42.2M
-5,783.15%-197.26M
Financing cash flow
Cash flow from continuing financing activities
36.36%1.46M
161,664.00%161.76M
-66.43%101.32M
10,221.10%99.29M
-99.70%867K
-5.66%1.07M
-99.32%100K
7.04%301.8M
-98.68%962K
452,263.49%284.99M
Net issuance payments of debt
----
----
--0
--0
----
----
----
68.95%125M
--0
----
Net common stock issuance
--0
--161.68M
-43.82%98.9M
--98.9M
--0
--0
--0
-15.15%176.05M
--0
--161.59M
Proceeds from stock option exercised by employees
36.36%1.46M
-18.00%82K
-17.56%2.42M
-59.67%388K
48.46%867K
-5.66%1.07M
-61.69%100K
39.44%2.94M
81.17%962K
826.98%584K
Net other financing activities
----
----
----
----
----
----
----
-33.60%-2.19M
--0
----
Cash from discontinued financing activities
Financing cash flow
36.36%1.46M
161,664.00%161.76M
-66.43%101.32M
10,221.10%99.29M
-99.70%867K
-5.66%1.07M
-99.32%100K
7.04%301.8M
-98.68%962K
452,263.49%284.99M
Net cash flow
Beginning cash position
131.65%190.71M
62.78%89.32M
-44.00%54.88M
30.95%108.4M
69.00%106.04M
15.91%82.33M
-44.00%54.88M
47.08%97.99M
55.25%82.78M
-30.80%62.75M
Current changes in cash
-546.42%-105.8M
268.87%101.46M
180.01%34.5M
31.40%-19.14M
-87.86%2.43M
386.09%23.7M
202.02%27.51M
-237.46%-43.12M
-162.46%-27.9M
153.63%20.03M
Effect of exchange rate changes
-388.89%-26K
-40.38%-73K
---50K
--68K
---75K
--9K
---52K
--0
--0
--0
End cash Position
-19.95%84.89M
131.65%190.71M
62.78%89.32M
62.78%89.32M
30.95%108.4M
69.00%106.04M
15.91%82.33M
-44.00%54.88M
-44.00%54.88M
55.25%82.78M
Free cash flow
32.42%-45.12M
60.71%-31.6M
11.93%-247.49M
20.98%-56.25M
51.41%-44.05M
-7.57%-66.76M
-40.85%-80.43M
-60.00%-281M
-36.98%-71.19M
-120.99%-90.65M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 32.14%-45.12M60.67%-31.6M4.14%-247.06M20.86%-56.24M35.03%-43.98M-7.27%-66.49M-41.02%-80.34M-47.58%-257.72M-37.43%-71.07M-65.58%-67.7M
Net income from continuing operations 26.28%-52.33M55.83%-35.38M15.83%-262.14M7.96%-66.28M58.44%-44.77M-5.32%-70.99M-24.53%-80.1M-50.93%-311.46M-0.97%-72.02M-89.03%-107.71M
Operating gains losses ---112K---543K--849K----------------------------
Depreciation and amortization -9.07%351K-1.38%358K62.85%1.52M10.95%385K37.23%387K149.03%386K142.00%363K105.73%934K155.15%347K143.10%282K
Other non cash items 1.28%1.11M1.85%1.1M-86.52%4.39M1.09%1.11M-96.37%1.11M129.89%1.09M129.51%1.08M10,435.60%32.56M1,364.00%1.1M40,046.05%30.51M
Change In working capital 25.48%-4.27M39.57%-5.44M-130.97%-23.5M105.54%411K-844.53%-9.18M-60.30%-5.73M-2,029.08%-9.01M-381.08%-10.18M-157.76%-7.41M-86.86%1.23M
-Change in receivables -16.65%-5.18M-163.21%-11.35M-105.12%-17.35M-6.02%-6.39M9.09%-2.21M---4.44M---4.31M---8.46M---6.03M---2.43M
-Change in inventory 67.08%-633K89.10%-113K25.21%-5.62M124.29%779K20.15%-3.44M---1.92M---1.04M---7.51M---3.21M---4.31M
-Change in prepaid assets -335.50%-2.17M329.32%5.54M-348.30%-8.62M24.98%1.47M-3,680.42%-8.59M-55.27%921K---2.42M147.37%3.47M196.62%1.17M-93.50%240K
-Change in payables and accrued expense 3,291.80%3.89M160.94%660K217.11%8.75M491.98%4.72M-33.32%5.23M97.80%-122K-222.32%-1.08M-74.24%2.76M-94.33%798K39.86%7.84M
-Change in other current liabilities -10.98%-182K-12.50%-180K-51.73%-657K-12.00%-168K-52.78%-165K-86.36%-164K-83.91%-160K-278.19%-433K-552.17%-150K-217.39%-108K
Cash from discontinued investing activities
Operating cash flow 32.14%-45.12M60.67%-31.6M4.14%-247.06M20.86%-56.24M35.03%-43.98M-7.27%-66.49M-41.02%-80.34M-47.58%-257.72M-37.43%-71.07M-65.58%-67.7M
Investing cash flow
Cash flow from continuing investing activities -169.72%-62.14M-126.63%-28.7M306.69%180.23M-247.36%-62.19M123.09%45.55M69.54%89.12M604.39%107.75M-14.81%-87.2M79.59%42.2M-5,783.15%-197.26M
Net PPE purchase and sale --0--0-28.53%-428K95.12%-6K-966.67%-64K-245.00%-276K33.87%-82K66.53%-333K52.87%-123K95.62%-6K
Net intangibles purchase and sale ----------0--0---------------22.95M--0----
Net investment purchase and sale -169.51%-62.14M-126.61%-28.7M382.65%180.66M-246.91%-62.18M126.17%45.61M69.81%89.39M599.26%107.83M14.73%-63.92M78.13%42.32M-4,931.10%-174.31M
Cash from discontinued investing activities
Investing cash flow -169.72%-62.14M-126.63%-28.7M306.69%180.23M-247.36%-62.19M123.09%45.55M69.54%89.12M604.39%107.75M-14.81%-87.2M79.59%42.2M-5,783.15%-197.26M
Financing cash flow
Cash flow from continuing financing activities 36.36%1.46M161,664.00%161.76M-66.43%101.32M10,221.10%99.29M-99.70%867K-5.66%1.07M-99.32%100K7.04%301.8M-98.68%962K452,263.49%284.99M
Net issuance payments of debt ----------0--0------------68.95%125M--0----
Net common stock issuance --0--161.68M-43.82%98.9M--98.9M--0--0--0-15.15%176.05M--0--161.59M
Proceeds from stock option exercised by employees 36.36%1.46M-18.00%82K-17.56%2.42M-59.67%388K48.46%867K-5.66%1.07M-61.69%100K39.44%2.94M81.17%962K826.98%584K
Net other financing activities -----------------------------33.60%-2.19M--0----
Cash from discontinued financing activities
Financing cash flow 36.36%1.46M161,664.00%161.76M-66.43%101.32M10,221.10%99.29M-99.70%867K-5.66%1.07M-99.32%100K7.04%301.8M-98.68%962K452,263.49%284.99M
Net cash flow
Beginning cash position 131.65%190.71M62.78%89.32M-44.00%54.88M30.95%108.4M69.00%106.04M15.91%82.33M-44.00%54.88M47.08%97.99M55.25%82.78M-30.80%62.75M
Current changes in cash -546.42%-105.8M268.87%101.46M180.01%34.5M31.40%-19.14M-87.86%2.43M386.09%23.7M202.02%27.51M-237.46%-43.12M-162.46%-27.9M153.63%20.03M
Effect of exchange rate changes -388.89%-26K-40.38%-73K---50K--68K---75K--9K---52K--0--0--0
End cash Position -19.95%84.89M131.65%190.71M62.78%89.32M62.78%89.32M30.95%108.4M69.00%106.04M15.91%82.33M-44.00%54.88M-44.00%54.88M55.25%82.78M
Free cash flow 32.42%-45.12M60.71%-31.6M11.93%-247.49M20.98%-56.25M51.41%-44.05M-7.57%-66.76M-40.85%-80.43M-60.00%-281M-36.98%-71.19M-120.99%-90.65M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg